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Abstract
Background: S100 proteins are a large family of calcium binding proteins present only in vertebrates. They
function intra- and extracellularly both as regulators of homeostatic processes and as potent effectors during
inflammation. Among these, S100A8 and S100A9 are two major constituents of neutrophils that can assemble
into homodimers, heterodimers and higher oligomeric species, including fibrillary structures found in the ageing
prostate. Each of these forms assumes specific functions and their formation is dependent on divalent cations,
notably calcium and zinc. In particular, zinc appears as a major regulator of S100 protein function in a disease
context. Despite this central role, no structural information on how zinc bind to S100A8/S100A9 and regulates
their quaternary structure is yet available.
Results: Here we report two crystallographic structures of calcium and zinc-loaded human S100A8. S100A8 binds
two zinc ions per homodimer, through two symmetrical, all-His tetracoordination sites, revealing a classical His-Zn
binding mode for the protein. Furthermore, the presence of a (Zn)2-cacodylate complex in our second crystal
form induces ligand swapping within the canonical His4 zinc binding motif, thereby creating two new Zn-sites,
one of which involves residues from symmetry-related molecules. Finally, we describe the calcium-induced S100A8
tetramer and reveal how zinc stabilizes this tetramer by tightening the dimer-dimer interface.
Conclusions: Our structures of Zn2+/Ca2+-bound hS100A8 demonstrate that S100A8 is a genuine His-Zn S100
protein. Furthermore, they show how zinc stabilizes S100A8 tetramerization and potentially mediates the formation
of novel interdimer interactions. We propose that these zinc-mediated interactions may serve as a basis for the
generation of larger oligomers in vivo.
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Background
S100 proteins belong to the EF-hand calcium-binding
protein superfamily and count more than 20 members
that are expressed exclusively in vertebrates, in a tissue-
and cell-specific manner [1, 2]. Under homeostatic
conditions, they are found in the cytoplasm or in the
nucleus of eukaryotic cells where they regulate vital pro-
cesses, generally in a calcium-dependent manner [1, 2].
S100 protein expression is often upregulated during in-
flammation. In addition, these proteins can be secreted
or passively released in the extracellular matrix where
they become damage-associated molecular patterns
(DAMPs) and exert cytokine-like functions, through
specific membrane-bound receptors [3–6], thus pro-
moting sustained inflammation and tissue damage in
various pathological settings associated with cardio-
vascular complications, neurodegenerative disorders
and cancers [1–3, 7]. As a consequence, S100 pro-
teins are considered both as valuable biological
markers and important therapeutical targets for vari-
ous inflammatory conditions [8, 9].
S100A8 and S100A9 constitute two of the most potent
pro-inflammatory molecules among the S100 protein
family [10]. They are constitutively expressed by leuko-
cytes of myeloid lineage [11, 12]. Although products of
distinct genes, the two proteins are often co-expressed
and account for up to 45 % of the total cytosolic protein
pool in human neutrophils [13]. As for all their conge-
ners, S100A8 and S100A9 form homodimers as a
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minimal, active unit [14, 15]. However, they usually exert
their physiological function as a S100A8/A9 heterodi-
mer, also termed calprotectin, and they can further asso-
ciate via heterotetramerization [16, 17]. The S100A8/A9
heterodimer is proposed to regulate various homeostatic
processes including fatty acid transport, cytoskeleton
reorganization and myeloid cell differentiation [18–20].
S100A8 and S100A9 have no signal sequences for clas-
sical secretion, but can be released from activated leuko-
cytes, either by active secretion via a tubulin-dependent
pathway, or by passive release, within neutrophil extra-
cellular traps (NETs) or from necrotic cells [21–23].
As for all S100 proteins, S100A8, S100A9, and their
heterodimer bind two calcium ions per monomer, one in
each EF-hand motif [14, 15, 17]. In addition to calcium,
calprotectin can bind Zn2+, Mn2+, Cu2+, and Fe2+ and,
by efficiently sequestrating these divalent cations in the
extracellular environment, it acts as a potent antimicro-
bial agent [24–28]. Interestingly, this antibacterial prop-
erty is restricted to the S100A8/A9 heterodimer [29]
although both homodimers are expected to bind zinc as
well, based on sequence comparisons [30]. Indeed, zinc
binding has been reported for several members of the
S100 protein family [30] and the determination of the
three-dimensional structures of both S100B, S100A7,
S100A12 and S100A15 complexed to zinc has revealed
two common, symmetrical zinc binding sites at the
dimer interface formed by highly conserved histidines
and possibly one or two aspartate/glutamate [31–34].
These Zn2+-coordinating residues are conserved in
S100A8 and S100A9, suggesting that both proteins could
bind zinc in a similar fashion. However, no structural
data are yet available to precisely characterize the zinc
binding mode of either S100A8 and S100A9 homodi-
mers or S100A8/A9 heterodimer. Zinc was furthermore
shown to enhance the oligomerization of these proteins,
either as homo- and heterotetramers or as much more
complex amyloid structures [35, 36]. Finally, it has been
proposed that the activity of extracellular S100 proteins,
including S100A8 and S100A9, would be regulated by
other divalent cations than calcium, notably Zn2+, since
the two EF-hand Ca2+-binding sites would be fully satu-
rated at all time in the extracellular compartment due to
the high calcium concentrations [30]. Zinc appears
therefore as an important regulator of the structural
organization and the resulting functional properties of
both S100A8 and S100A9. However, no structural infor-
mation is yet available to decipher the intimate mecha-
nisms by which this regulation is achieved.
To better understand how zinc modulates the structure-
function relationship of S100A8 and S100A9, we have
undertaken the structural studies of these S100 proteins in
the presence of zinc. Here we report the crystallographic
structures of human S100A8 (hS100A8) bound to zinc
and calcium at 2.2 and 2.1 Å, respectively. The first struc-
ture reveals a classical, all-histidine zinc-binding motif,
thereby classifying S100A8 as a genuine His-Zn S100 pro-
tein. The second structure displays an atypical (Zn)2-caco-
dylate complex in one of the two Zn-sites per homodimer,
leading to ligand swapping and creation of two novel Zn-
sites. Analysis of the quaternary arrangement of hS100A8
in both crystal forms suggests that zinc enhances tetramer
stabilization and could further participate in the formation
of higher oligomeric species and/or in the interaction with
S100A8 binding partners.
Results and discussion
A classical His-Zn binding motif
In the presence of both zinc and calcium, hS100A8 gave
rise to two new crystal forms displaying a P212121 and a
C2221 symmetry, as compared to Ca
2+-bound hS100A8
which crystallized in P3121 [14] (Table 1). Both structures
could nevertheless be solved by molecular replacement
using the previously reported Ca2+-hS100A8 homodimer
structure. For crystal form 2 (C2221), structure determin-
ation was also successful using SAD-phasing in PHENIX.-
AUTOSOLVE [37] from the dataset collected at the Zn
peak (λ = 1.27 Å) (Additional file 1: Table S1). In that case,
12 sites were identified corresponding to the eight Zn2+
ions and four of the eight Ca2+ ions (Additional file 2: Fig-
ure S1a). The overall figures of merit after SAD-phasing
and after density modification using RESOLVE were 0.36
and 0.73, respectively (35–2.1 Å resolution cut-off). In any
case, the position of the zinc ions could be unambiguously
identified in both structures from anomalous difference
Fourier maps calculated using phases and figure of merit
weights from the best refined atomic model containing no
ions obtained with the native dataset and anomalous
differences from the datasets collected at wavelengths of
1.27 and 1.30 Å (Additional file 1: Table S1, Fig. 1a and
Additional file 2: Figure S1b-c).
The overall structure of Zn2+/Ca2+-bound hS100A8
from crystal form 1 is displayed in Fig. 1b. The protein
arranges in a canonical homodimer that contains four
calcium ions, one in each EF-hand, and two zinc ions at
the interface between the two monomers (Fig. 1b).
Although zinc can replace calcium in the EF-hand mo-
tifs when present alone [35], only Ca2+ was found in all
EF-hands of our model as judged from the anomalous
difference Fourier maps (Fig. 1a). The two symmetrical
Zn-sites are formed by two residues from each mono-
mer: from the first monomer, His17 in helix H1 and
His27 in the first EF-hand, and from the second mono-
mer, His83 and His87 at the C-terminus of helix H4
(Fig. 1c). His27 appears however somewhat flexible and
in two out of the eight molecules present in the asym-
metric unit of our structure, it is flipped away from the
Zn-site by around 45°, the missing coordination being
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instead provided by a chloride ion (Fig. 1d). In any
case, the Zn-binding mode of hS100A8 is very similar
to that of the four other S100 proteins for which
crystal structures in the presence of zinc have been
reported, namely S100A7, S100A12, S100A15, and
S100B [31–34] (Additional file 3: Figure S2), with the
particularity that S100A8 is the sole among these
S100 proteins to display an all-histidine zinc binding site.
Our structural data therefore clearly confirm that hS100A8
belongs to the His-Zn group of S100 proteins.
An atypical Zn-site formed by a (Zn)2-cacodylate complex
Surprisingly, in the structure derived from crystal form
2, four zinc ions per homodimer were present in
addition to the four calcium ions (Fig. 2a). A closer
inspection of the structure revealed that only one of the
two symmetrical Zn-sites found in crystal form 1 was
strictly conserved (Zn2) whereas the second site (Zn1)
was instead replaced by a (Zn)2-cacodylate complex, the
cacodylate molecule coming from the crystallization
condition (Fig. 2b). In this new site, Zn1 (crystal form 2)
occupies almost the same position as Zn1 from crystal
form 1 and is coordinated by His17 from monomer A
and His83 from monomer B. The two other coordinat-
ing His residues are however replaced by a chloride ion
and by one of the hydroxyl groups of the cacodylate
molecule. Instead, His27 from monomer A and His87
from monomer B are flipped by 70 and 100°, respectively.
As a consequence, His27 now coordinates the second Zn2
+ (Zn3) from the (Zn)2-cacodylate complex which is fur-
ther held in place by His91 from monomer B, by a second
chloride ion and by the second hydroxyl group of the caco-
dylate molecule. Finally, the new position of His87 leads to
the creation of a third Zn-site (Zn4) which is completed by
Glu93 from the very C-terminal end of helix H4 (mono-
mer B), Glu57 from a symmetry-related molecule, and a
third chloride ion (Fig. 2b). Despite this quite large re-
arrangement of one of the Zn-sites in crystal form 2, the
resulting S100A8 homodimer structure remains unaffected
and superimposes well with the homodimer from crystal
form 1, with an overall root-mean-square deviation
(r.m.s.d.) on Cα atoms of 0.464 Å. Hence it seems possible
to accommodate more than just one Zn2+ ion at the dimer
interface within S100A8, and, in addition to the four con-
served histidines from the canonical Zn-binding motif,
other residues such as His91 or Glu93 can participate in
zinc coordination. Whether such additional Zn2+ sites
occur in vivo and what their functional relevance might be
still remains to be determined.
Influence of divalent cations on S100A8 oligomerization
The Zn2+/Ca2+-hS100A8 homodimer we observe is
highly similar to the previously reported Ca2+-hS100A8
homodimer [14] with an r.m.s.d. on Cα atoms of 0.65
and 0.45 Å between the Ca2+-loaded homodimer and
the Zn2+/Ca2+-bound homodimers from crystal forms 1
and 2, respectively (Fig. 3a). The most prominent
changes are observed for the C-terminal part of helix
H4, which even forms an additional helix turn in the
model derived from crystal form 2. In crystal form 1,
Table 1 Data collection and refinement statistics
Crystal form 1 Crystal form 2
Data collection
Diffraction source I911-3, MAX-lab I911-3, MAX-lab
Wavelength (Å) 1.0 1.0
Space group P212121 C2221
a, b, c (Å) 50.93, 85.09, 197.20 55.98, 90.03, 196.80
α, β, γ (°) 90, 90, 90 90, 90, 90
Mosaicity (°) 0.14 0.25
Resolution range (Å) 50–2.2 (2.3–2.2) 50–2.1 (2.2–2.1)
Total No. of reflections 262,642 232,345
No. of unique reflections 42,972 29,069
Completeness (%) 96.5 (99.6) 98.5 (97.8)
Redundancy 6.1 (6.0) 8.0 (8.2)
I/σ(I) 12.54 (3.08) 16.47 (3.04)
Rmeas 14.8 (78.8) 9.5 (86.4)
Wilson B factor (Å2) 30.6 37.1
Refinement
Resolution range (Å) 40–2.2 49–2.1
No. reflections, working +
test set
41,886 28,412
Final Rwork/Rfree (%) 18.19/21.66 17.85/19.70







Bonds (Å) 0.002 0.002
Angles (°) 0.439 0.521






Favored regions (%) 99.4 99.7
Additionally allowed (%) 0.6 0.3
Outliers (%) 0 0
Values for the outer shell are given in parentheses
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helix H4 is not involved in crystal packing. In crystal
form 2, helix H4 only interacts with Glu57 from a
symmetry-related molecule due to the presence of the
(Zn)2-cacodylate complex. The movement observed for
helix H4 in both crystal forms is therefore more likely
due to the presence of the Zn sites rather than to a dif-
ferent crystal packing as compared to Ca2+-hS100A8.
Minor changes, mostly side chain repositioning of resi-
dues near the zinc binding pocket, are also noted around
the two calcium EF-hands. Zinc binding was reported to
increase both calcium affinity and target recognition for
several S100 proteins, including S100B and S100A12
[30, 38, 39]. Based on structural data, it was proposed
that increased target recognition is due to the reposi-
tioning of helix H4 C-terminus, which is believed to
delineate the substrate binding cleft for many S100 pro-
teins, whereas higher affinity for calcium is due to the
stabilization of the Ca2+-bound EF-hands active con-
formation [32, 34], although no major conformational
changes are observed around the EF-hands between the
Ca2+-bound form and the Zn2+/Ca2+-bound form of
both S100B and S100A12. In our crystal structures of
Zn2+/Ca2+-hS100A8, the two calcium EF-hands super-
impose well with the EF-hands of Ca2+-hS100A8 [32],
as shown in Fig. 3a, and no major side chain reposi-
tioning is observed except for the residues involved in
zinc coordination. However, a closer inspection of the
Ca-O distances between the calcium ions and their
coordinating residues present in the EF-hands of both
Ca2+-hS100A8 and our two Zn2+/Ca2+-hS100A8 struc-
tures reveals that several of these Ca-O distances are
significantly shortened upon Zn-binding (Table 2).
Such direct comparison is possible since all three
structures were solved at similar resolutions around
(a) (b)
(c) (d)
Fig. 1 The crystallographic structure of Zn2+/Ca2+-bound hS100A8. a Anomalous difference Fourier maps calculated using phases and weight
from the best refined atomic model (without ions) obtained with the native dataset (crystal form 1) and anomalous differences from the datasets
collected at wavelengths of 1.27 Å (cyan mesh, contour at 3.5 σ) and 1.30 Å (red mesh, contour at 3.5 σ). The final model displayed as cartoon in
beige and purple is superimposed for comparison. The anomalous signal clearly disappears for the wavelength above the Zn maximal absorbance
peak (λ = 1.30 Å) as judged by the fact that almost no density is visible for the second anomalous difference Fourier map (red mesh). b Overview of
the structure of Zn2+/Ca2+-bound hS100A8 derived from crystal form 1 at 2.2 Å resolution showing two zinc bound at the homodimer interface
(yellow spheres). The four calcium ions are displayed as green spheres. c Close-up view on the Zn2+-binding site revealing an all-His binding motif
formed by two residues from each monomer. d In two out of eight molecules within the asymmetric unit, His27 from monomer A is replaced by a
chloride ion (gray sphere)
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2 Å. Thus calcium binding by hS100A8 seems to be
tighter in the presence of zinc. These observations
taken together with the fact that the changes ob-
served in hS100A8 upon zinc binding are very similar
to those described for S100B and S100A12 suggest
that calcium affinity could be enhanced by Zn2+ for
hS100A8. As we do not know where interacting part-
ners would bind on hS100A8, we cannot conclude
whether Zn2+ could also have an effect on target rec-
ognition for S100A8 or not.
Oligomerization of S100 proteins strongly relies on
divalent cations [40]. As for many other S100 proteins,
S100A8 and S100A9 can readily form homo- and het-
erodimers in the absence of calcium [35] but the forma-
tion of the (S100A8/S100A9)2 heterotetramer is strictly
Ca2+-dependent [17, 35]. Since the (S100A8/S100A9)2
heterotetramer is the most abundant form for the two
proteins in vivo, most studies to evaluate the influence
of divalent cations on S100A8/A9 have been performed
on this oligomer. Thus little is known about the behav-
iour of S100A8 and/or S100A9 homo-oligomers in the
presence of zinc, despite the fact that these forms have
functions of their own [41, 42] that might also be regu-
lated by divalent cations. In the sole presence of calcium,
we observe that hS100A8 elutes as two separate oligo-
meric forms on a size exclusion chromatography (SEC)
column (Fig. 3b). Based on the calibration curve of the
SEC column (Additional file 4: Figure S3), we calculated
that these two forms respectively encompass 2.5 (peak
1) and 1.25 (peak 2) S100A8 homodimers, and we there-
fore assigned them as homotetramer and homodimer,
respectively. Thus, S100A8 homodimers can further as-
sociate into homotetramers during SEC. This tetrameric
form was already noticeable in the crystal packing of the
Ca2+-hS100A8 structure [14] although the authors did
not comment on it. We observe a similar tetramer in
our two distinct crystal forms (Fig. 3c) and the total bur-
ied surface area at the dimer-dimer interface is 1024 Å2
per dimer according to PISA [43]. Interestingly, the
same tetrameric arrangement is observed for the
(S100A8/S100A9)2 heterotetramer [17, 28] and all four
tetramers superimpose quite well (Fig. 3c) suggesting
that this tetramer is not dependent on very specific
crystallization conditions and therefore may correspond
to the tetramer observed in our size exclusion chroma-
tography experiment. Within the hS100A8 homotetra-
mer, the two homodimers are held in place by two
symmetrical interfaces formed by the insertion of the
second EF-hand from monomer B into the cleft between
the two EF-hands of monomer A from the opposite
homodimer (Fig. 3d). In particular, the carbonyl groups of
the main chain of Lys56, Glu57, Asp59 and Ile60 (mono-
mer B) interact with the side chains of either Asn25 or
Tyr30 (1st EF-hand, monomer A) while Gln69 carbonyl
group (monomer B) connects with the side chain of Asn61
(2nd EF-hand, monomer A). Interestingly, in Ca2
+-hS100A8, the second hS100A8 homodimer is pulled
away from the interface on one side, due to the slightly dif-
ferent orientation of helix H4 (Fig. 3c). As a consequence,
one of the two homodimer-homodimer interfaces is
strongly destabilized due to the breaking of the hydrogen
bonds made by Asn25 side chain and the lengthening of all
the other interactions described above (Fig. 3d). These
observations suggest that zinc further enhances
stabilization of the S100A8 tetramer.
Conclusions
Here we report the crystal structure of human S100A8 in
the presence of both calcium and zinc. The structure
(a)
(b)
Fig. 2 The atypical (Zn)2-cacodylate complex present in crystal form
2 induces the formation of new Zn-sites. a Superimposition of the
hS100A8 homodimers from crystal form 1 (beige and purple with
Zn2+ ions in orange) and crystal form 2 (cyan and salmon with Zn2+
ions in yellow), respectively. Only one Zn-site (Zn2) is conserved
between the two structures. b Close-up view on the new Zn-sites
observed in the structure derived from crystal from 2. The presence
of the (Zn)2-cacodylate complex induces ligand swapping and the
formation of two novel Zn-sites (Zn3 and Zn4)
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reveals an all-histidine Zn-binding site and demonstrates
that hS100A8 belongs to the His-Zn group of S100 pro-
teins, as expected from sequence comparisons. The struc-
ture further reveals that zinc allows tightening of the
dimer-dimer interface within hS100A8 homotetramer, thus
pointing towards an enhancing role of zinc in S100A8 tet-
ramerization. Our data therefore suggest that, as for several
other S100 proteins, divalent cations, and notably zinc, in-
fluence S100A8 oligomerization. The second Zn2+/Ca2
+-hS100A8 structure presented here describes how an
atypical (Zn)2-cacodylate complex can insert into one of
the canonical Zn-sites and disrupt the classical His4 tetra-
coordination sphere, inducing ligand swapping and the for-
mation of two new Zn-sites. This is not unique to S100A8
as a pH-dependent ligand swapping for zinc coordination
has also been described for S100B [32]. Furthermore, both
S100A8 and S100A9 contains several histidine residues on
their C-termini and they can all be involved in the coordin-
ation of divalent cations as seen in our S100A8 structures
or in the structures of Mn2+-bound calprotectin [28, 44].
Taken together with our structural data, these observations
suggest that the histidine-rich C-termini of both S100A8
and S100A9 are quite flexible and prone to ligand swap-
ping in the presence of divalent cations. Reorganization of
the canonical Zn-sites leading to the involvement of new
Zn-coordinating residues and/or the creation of new Zn-
sites, possibly at the interface between two S100 dimers or
between S100A8 and a binding partner, is a plausible sce-
nario that could also occur in vivo under specific condi-
tions. Ligand swapping in these flexible C-terminal regions
could therefore potentially contribute to the formation of
novel interdimer interactions, through ions coordination,
that would lead to the formation of higher oligomeric spe-
cies. Similarly, reorganization of the flexible C-terminus of
both S100A8 and S100A9 by ligand swapping could induce
the formation of cation binding sites at the interface be-
tween these S100 proteins and specific binding targets, the
metal coordination being provided by both interacting
partners. Such mechanisms would provide a structural
rationale for the influence of zinc on S100:target
(a) (b)
(c) (d)
Fig. 3 Oligomeric states of hS100A8 in the presence of divalent cations. a Superimposition of the Zn2+/Ca2+-bound hS100A8 homodimers from
crystal form 1 (beige) and crystal form 2 (cyan) with Ca2+-hS100A8 (dark blue) [14]. The major regions of divergence are indicated with red arcs.
b Elution profile of hS100A8 on a 24 ml Superdex 75 size exclusion chromatography column (Ge Healthcare Life Sciences) equilibrated in 20 mM
HEPES pH 7.5, 200 mM NaCl, 5 mM CaCl2. Ca
2+-hS100A8 elutes as two peaks with elution volumes of 11.15 and 12.8 ml, respectively, most likely
corresponding to a tetramer and a dimer, respectively. c Superimposition of the Zn2+/Ca2+-bound hS100A8 homotetramers from crystal
form 1 (yellow) and crystal form 2 (cyan) with the homotetramer derived from the crystal packing in Ca2+-hS100A8 (dark blue, [14]) and
with the (S100A8/S100A9)2 heterotetramer (salmon, [17]). The red arrow indicates the movement of one S100A8 homodimer away from
the other homodimer on one side of the dimer-dimer interface in the calcium-loaded hS100A8 [14]. d Close-up view on the interactions
stabilizing the homodimer-homodimer packing within the hS100A8 homotetramer from Ca2+-hS100A8 (purple) and from Zn2+/Ca2+-hS100A8 (yellow,
crystal from 1)
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recognition, as well as on the formation of S100A8/A9
amyloid-like structures which is known to be regulated by
both calcium and zinc [36, 40].
Methods
Cloning, expression and purification of human S100A8
The gene coding for hS100A8, codon-optimized for
bacterial expression, was purchased from Genscript (Gen-
Script USA Inc.) and recloned into the Nco I – Hind III
fragment of vector pETM13 (EMBL vector collection) to
allow expression of the protein without any tags. To be in
frame with the start codon in pETM13, two additional nu-
cleotides (C + A) were introduced in between the Nco I
site and the beginning of the hS100A8 sequence, yielding
a protein with an additional alanine residue in between
the initial methionine and the following leucine residue.
hS100A8 was expressed in Escherichia coli BL21(DE3)
cells and purified in a three-step procedure including
affinity chromatography on a 5 ml HisTrap FF Ni-column
(GE Healthcare Life Sciences), anion exchange on a 9 ml
Source 15Q column (GE Healthcare Life Sciences) and
size exclusion chromatography (SEC) on a 120 ml home-
packed Superdex 75 column. BL21(DE3) cells transformed
with the hS100A8-pETM13 plasmid were grown at 310 K
until their absorbance at 600 nm reached 0.6–0.8. Protein
expression was then induced overnight at 291 K by
addition of 1 mM IPTG. The cells were harvested by cen-
trifugation, resuspended in a buffer containing 50 mM
HEPES pH 7.5, 200 mM NaCl, 30 mM imidazole, 1 mM
PMSF (Buffer A) and disrupted by sonication. After clarifi-
cation by centrifugation, the supernatant was loaded onto
the 5 ml Ni-column equilibrated in Buffer A and the non-
specifically bound contaminants were washed off with
high salt (Buffer A containing 1 M NaCl). As hS100A8
contains several histidine residues on its C-terminus, it
binds relatively strongly to the Ni-column, even in the ab-
sence of a His-tag, and could be eluted with a buffer con-
sisting of 50 mM HEPES pH 7.5, 200 mM NaCl, 250 mM
imidazole, 1 mM PMSF. The protein was then dialyzed
overnight at 277 K against 50 mM Tris-HCl pH 8.8,
50 mM NaCl and loaded onto the anion-exchange col-
umn. Elution was performed with a 100 ml gradient from
50 to 300 mM NaCl. hS100A8 appeared in the run-
through fraction and in the first fractions of the gradient
while most of the contaminants bound more strongly to
the Source 15Q column. The hS100A8-containing frac-
tions were pooled and concentrated to 5 ml before loading
onto the SEC column equilibrated in 20 mM HEPES
pH 7.5, 100 mM NaCl, 5 mM CaCl2. The protein eluted
as two separate peaks (Fig. 3b and Additional file 4: Figure
S3). Fractions corresponding to each oligomeric form
were pooled separately, concentrated and aliquoted before
flash-freezing in liquid nitrogen for storage at 193 K.
To determine the molecular weight of the two oligo-
meric forms of hS100A8 obtained during SEC (Additional
file 4: Figure S3), an aliquot of the pooled hS100A8 sample
obtained after the Source 15Q column was also run onto
a 24 ml Superdex 75 column (GE Healthcare) equilibrated
in 20 mM HEPES pH 7.5, 200 mM NaCl, 5 mM CaCl2
Table 2 Average Ca-O distances in the two calcium EF-hands of the different hS1008 structures in Å
The Ca-O distances for which a significant change is observed upon Zn2+ presence are highlighted in blue
Lin et al. BMC Structural Biology  (2016) 16:8 Page 7 of 10
and connected to a BioLogic DuoFlow HPLC system
(BioRad). Calibration of the SEC column was performed
in the same buffer as for the S100A8 run using the Gel
Filtration Markers Kit for Protein Molecular Weights
6500–66000 Da (Sigma-Aldrich).
Crystallization of Zn2+/Ca2+-hS100A8
Crystallization of hS100A8 in the presence of zinc was
performed with both the dimeric (10 mg ml−1) and the
tetrameric (3.2 mg ml−1) forms of the protein after add-
ing 3 mM ZnCl2 to the protein solution. Crystallization
was carried out using the sitting-drop vapor-diffusion
technique in 96-well Swissci MRC crystallization plates
with the help of a MOSQUITO robot (TTP LabTech)
and commercial screens from Hampton Research
(INDEX screen) and Molecular Dimensions Ltd (Struc-
ture Screen, PROPLEX, MacroSol and Stura Footprint
screens). Several hits were obtained for the dimeric form
whereas only a few small crystals appeared for the tetra-
mer, probably due to the much lower protein concentra-
tion imposed by precipitation at higher concentrations.
Two conditions were further optimized by varying the
precipitant concentration, pH, ionic strength, and pro-
tein concentration, and by screening with an additive
collection (Hampton Research). The final optimal condi-
tions were 0.2 M ammonium acetate, 0.1 M Na acetate
pH 4.0, 15 % PEG 3350, 0.4 % 2,2,2-trifluoroethanol for
crystal form 1 and 5 mM ZnCl2, 0.1 M Na cacodylate
pH 6.5, 8 % PEG 8000 for crystal form 2.
Data collection and structure determination
Before flash-cooling into liquid nitrogen, crystals were
soaked a few seconds into a cryoprotective solution cor-
responding to the reservoir of their crystallization drop
but containing 35 % PEG 3350 instead of 15 % (crystal
form 1) or with 25 % glycerol added (crystal form 2).
Diffraction data were collected at 100 K on the I911-3
beamline at MAX-lab (Lund, Sweden) (Table 1). For
each crystal, three complete datasets were collected: a
native dataset at 1.0 Å, a single-wavelength anomalous
dispersion (SAD) dataset at the Zn peak (λ = 1.27 Å),
and a third dataset after the Zn peak (λ = 1.30 Å). All
datasets were processed and scaled using XDS [45].
Crystal form 1 displayed a P212121 symmetry with
eight molecules of hS100A8 per asymmetric unit and
diffracted to a maximal resolution of 2.2 Å. Crystal form
2 displayed a C2221 symmetry with four molecules of
hS100A8 per asymmetric unit and the data could be
processed to a maximum resolution of 2.1 Å. Both struc-
tures were solved by molecular replacement with
PHASER [46] from the PHENIX package [37] using the
structure of human S100A8 bound to calcium [14] as a
search model. Refinement of the initial models was car-
ried out by alternating cycles of manual rebuilding in
COOT [47] and cycles of positional refinement with
PHENIX.REFINE [37] using individual isotropic Atomic
Displacement Parameters (ADP) as well as Translation–
Libration–Screw (TLS) parameterization (Table 1). The
final models were validated with Molprobity [48]. All
figures were made with the Pymol Molecular Graphics
System (version 0.99rc6, DeLano Scientific LLC).
Ethics
Ethics was not requested for this study since it does
not involved human participants or animals, and the
human protein we crystallized was expressed recom-




Availability of data and materials
The coordinates and structure factors for the structures
of Zn2+/Ca2+-hS100A8 from crystal forms 1 and 2 have
been deposited in the Protein Data Bank with accession
numbers 5HLV and 5HLO, respectively. Additional files
can be found on the online version of this paper and
contain Additional file 1: Table S1, Additional file 2: Fig-
ure S1, Additional file 3: Figure S2 and Additional file 4:
Figure S3. The legend for all the additional files is specified
at this end of this article.
Additional files
Additional file 1: Table S1. Data collection and processing statistics
for the datasets collected at wavelengths of 1.27 Å and 1.30 Å for both
crystal forms 1 and 2. Values for the outer shell are given in parentheses.
All datasets were processed with XDS [45] with the Friedel pairs kept
separated. (DOCX 24 kb)
Additional file 2: Figure S1. Identification of the new Zn-sites in the
Zn2+/Ca2+-hS100A8 structure derived from crystal form 2 (C2221). (a)
Experimental map containing anomalous data obtained after SAD-phasing
in PHENIX.AUTOSOLVE [37] displayed as magenta mesh and contoured at
3.5 σ. The final refined model is superimposed for comparison. 12
anomalous sites were identified, including the 8 Zn2+ sites and 4
of the 8 Ca2+ sites (Ca2, Ca3, Ca6 and Ca8). (b) Anomalous difference
Fourier map calculated using phases and weight from the best refined
atomic model (without ions) obtained with the native dataset (crystal form
2) and anomalous differences from the datasets collected at a wavelength
of 1.27 Å (magenta mesh, contour at 3.5 σ). (c) Anomalous difference Fourier
map calculated using phases and weight from the best refined atomic
model (without ions) obtained with the native dataset (crystal form 2) and
anomalous differences from the datasets collected at a wavelength of
1.30 Å (red mesh, contour at 3.5 σ). The anomalous signal disappears for
all Zn2+ ions but remains for the Ca2+ ions. (PDF 1749 kb)
Additional file 3: Figure S2. Close-up view on the His-Zn binding motif
of several S100 proteins. (a) Crystallographic structure of hS100A7 in the
presence of both zinc and calcium [31]. (b) Crystallographic structure of
hS100A12 in the presence of zinc and in the absence of calcium [34]. (c)
Crystallographic structure of hS100A15 in the presence of both zinc and
calcium [33]. (d) Crystallographic structure of hS100B in the presence of
both zinc and calcium [32]. (PDF 2784 kb)
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Additional file 4: Figure S3. Calibration of the Size Exclusion
Chromatography (SEC) column and composition of the two oligomeric
forms obtained by SEC for hS100A8. (a) Theoretical molecular weights
and measured elution volumes of the different protein standards used
for calibration of the 24 ml SEC column (Superdex 75, GE Healthcare
Lifesciences). The calibration was performed in 20 mM HEPES pH 7.5,
200 mM NaCl and 5 mM CaCl2. (b) Calibration curve derived from the SEC
runs with the different protein standards. (c) Elution profile of hS100A8 on
the SEC column equilibrated in 20 mM HEPES pH 7.5, 200 mM NaCl and
5 mM CaCl2. In the sole presence of calcium, hS100A8 elutes as two peaks
with elution volumes of 11.15 (Peak 1) and 12.80 (Peak 2), respectively.
(d) Molecular weights for the two hS100A8 species and corresponding
molecular composition extrapolated from the calibration curve. The
equation used to calculate the molecular weights is indicated above the
table. (PDF 107 kb)
Abbreviations
DAMPs: damage-associated molecular patterns; hS100A8: human S100A8;
NETs: neutrophil extracellular traps; r.m.s.d.: root mean square deviation;
SEC: size exclusion chromatography.
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